Pluvicto, a prostate cancer drug, has gained expanded approval that triples the number of patients with metastatic disease ...

Pfizer on Monday announced it is halting development of a daily weight loss pill after one patient experienced a liver injury ...

Pharmaceutical Technology is the independent source for information, insight, and analysis on bio/pharmaceutical formulation, ...

Ghent, Belgium, 8 April 2025 – Sequana Medical NV (Euronext Brussels ... reference is made to the Company's press release dated 18 March 2025, announcing the entering into the Facility and ...

Drugmaker Eli Lilly said Thursday that an experimental pill form of popular GLP-1 medications helped people with type 2 ...

Democratic Party leaders in San Francisco today unveiled a striking package of resolutions designed to help their party find ...

Scientists believe they may have found the reason why some people get so sick the contrast dye you get before an MRI.

A copy of the release will be available on the Globus Medical website at ... of Globus Medical and Nevro contained in each company’s most recent annual report on Form 10-K filed with the U.S.

A new GLP-1 drug, orforglipron, comes in pill form and appears to be roughly as effective as injected drugs like Ozempic.

Headshot — Attach in PDF format Dance Resume — Attach in PDF format Cougarette Release-Waiver Form — Download, complete and attach in PDF format Pre-Participation Physical Exam Form — All applicants ...

C. diff typically infects people whose gut bacteria has been wiped out by powerful antibiotics, according to the U.S. Centers ...

Pfizer said it would end development of its experimental daily weight loss pill after a patient experienced a liver injury ...